Volume 36, Issue 1 pp. 31-40
ORIGINAL ARTICLE

Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions with potential explanation of false-negative cytology: A multi-institutional analysis

Kotaro Takeda

Kotaro Takeda

Department of Pathology and Laboratory Medicine, Yale New Haven Hospital, Yale University, New Haven, Connecticut, USA

Search for more papers by this author
Catherine Gereg

Catherine Gereg

Department of Pathology and Laboratory Medicine, Yale New Haven Hospital, Yale University, New Haven, Connecticut, USA

Search for more papers by this author
Xiaoying Liu

Xiaoying Liu

Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

Search for more papers by this author
Weijie Ma

Weijie Ma

Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

Search for more papers by this author
Mayara Bearse

Mayara Bearse

Department of Pathology and Laboratory Medicine, Yale New Haven Hospital, Yale University, New Haven, Connecticut, USA

Search for more papers by this author
Haiming Tang

Haiming Tang

Department of Pathology and Laboratory Medicine, Yale New Haven Hospital, Yale University, New Haven, Connecticut, USA

Search for more papers by this author
Isabela Delfino

Isabela Delfino

Universidade de Uberaba, Uberaba, Brazil

Search for more papers by this author
Eric Huang

Eric Huang

Department of Pathology, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Xiaoqi Lin

Xiaoqi Lin

Department of Pathology, Northwestern Memorial Hospital, Northwestern University, Chicago, Illinois, USA

Search for more papers by this author
Jocelyn B. Chandler

Jocelyn B. Chandler

Department of Pathology and Laboratory Medicine, Yale New Haven Hospital, Yale University, New Haven, Connecticut, USA

Search for more papers by this author
He Wang

Corresponding Author

He Wang

Department of Pathology and Laboratory Medicine, Yale New Haven Hospital, Yale University, New Haven, Connecticut, USA

Correspondence

He Wang, Department of Pathology, Yale School of Medicine, 20 York Street, New Haven 06510, CT, USA.

Email: [email protected]

Search for more papers by this author
First published: 20 September 2024
Citations: 1

Kotaro Takeda and Catherine Gereg have been contributed equally to this work.

Abstract

Objective

Malignant pericardial effusions are associated with a poor prognosis. Pericardial fluid cytology and pericardial biopsy are the primary methods for diagnosis. This study aimed to conduct a multi-institutional analysis to compare the diagnostic sensitivity of cytology and biopsy, and to investigate potential explanations for false-negative results in cytology.

Methods

A retrospective review of pericardial fluid cytology cases with concurrent biopsy was conducted across four different institutions. Results were compared using standard statistical methods with attention to sensitivity and histologic distribution. False-negative cytology cases were investigated for further exploration.

Results

A total of 309 cases were collected, of which 99 (32.0%) were confirmed malignant through repeat sampling or clinical history. Pericardial fluid cytology and biopsy identified 84 and 64 malignant cases, respectively. Our findings confirmed significantly higher sensitivity of cytology compared to biopsy (84.8% vs 65.7%). The most common sites of origin were lung, breast, and gastrointestinal, with adenocarcinoma being the most prevalent histologic subtype. Histologic review of 12 false-negative cytology cases revealed three key explanations; lymphoma was the most common missed diagnosis (33.3%); fibrinous pericarditis obscures neoplastic cells on the pericardial surface; and pericardial involvement can be seen without extension into the pericardial space.

Conclusion

This study demonstrated diagnostic superiority of pericardial fluid cytology over biopsy in the evaluation of malignant pericardial effusions. We identified several limitations in fluid cytology causing false negatives. In the context of an underlying malignancy with pericardial effusion, pathologists should consider immunohistochemistry studies to aid on the diagnosis.

Graphical Abstract

Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions. Lung adenocarcinoma is the most common type in malignant pericardial effusion.

A multi-institutional study reviewed 309 cases of pericardial fluid cytology and pericardial biopsy, highlighting greater sensitivity of cytology (84.8%) with the most common primaries being lung, breast, gastrointestinal, and haematologic origin. The study also commented on the impact of ancillary testing, volume of pericardial fluid submitted for analysis, and utilization of molecular diagnostics like cfDNA methylation analysis for further enhancement of diagnostic accuracy and improved patient outcomes.

CONFLICT OF INTEREST STATEMENT

All authors declare that they have no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.